118 related articles for article (PubMed ID: 21550372)
21. A serum protein factor mediates maturation and apoB-association of HCV particles in the extracellular milieu.
Denolly S; Granier C; Fontaine N; Pozzetto B; Bourlet T; Guérin M; Cosset FL
J Hepatol; 2019 Apr; 70(4):626-638. PubMed ID: 30553840
[TBL] [Abstract][Full Text] [Related]
22. Isolation and characterization of an Huh.7.5.1-derived cell clone highly permissive to hepatitis C virus.
Shirasago Y; Sekizuka T; Saito K; Suzuki T; Wakita T; Hanada K; Kuroda M; Abe R; Fukasawa M
Jpn J Infect Dis; 2015; 68(2):81-8. PubMed ID: 25420655
[TBL] [Abstract][Full Text] [Related]
23. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus expressing flag-tagged envelope protein 2 has unaltered infectivity and density, is specifically neutralized by flag antibodies and can be purified by affinity chromatography.
Prentoe J; Bukh J
Virology; 2011 Jan; 409(2):148-55. PubMed ID: 21095619
[TBL] [Abstract][Full Text] [Related]
25. [Infection of tupaia hepatocytes with hepatitis C virus in vitro].
Zhao XP; Tian ZF; Chen YC; Yang C; Tian DY; Yang DL; Hao LJ
Zhonghua Gan Zang Bing Za Zhi; 2005 Nov; 13(11):805-7. PubMed ID: 16313720
[TBL] [Abstract][Full Text] [Related]
26. Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization.
Scheel TK; Gottwein JM; Jensen TB; Prentoe JC; Hoegh AM; Alter HJ; Eugen-Olsen J; Bukh J
Proc Natl Acad Sci U S A; 2008 Jan; 105(3):997-1002. PubMed ID: 18195353
[TBL] [Abstract][Full Text] [Related]
27. Centrifugal enhancement of hepatitis C virus infection of human hepatocytes.
Ye L; Wang X; Wang S; Luo G; Wang Y; Liang H; Ho W
J Virol Methods; 2008 Mar; 148(1-2):161-5. PubMed ID: 18178263
[TBL] [Abstract][Full Text] [Related]
28. Primary human hepatocytes in spheroid formation to study hepatitis C infection.
Chong TW; Smith RL; Hughes MG; Camden J; Rudy CK; Evans HL; Sawyer RG; Pruett TL
J Surg Res; 2006 Jan; 130(1):52-7. PubMed ID: 16154152
[TBL] [Abstract][Full Text] [Related]
29. Efficient replication systems for hepatitis C virus using a new human hepatoma cell line.
Kato N; Mori K; Abe K; Dansako H; Kuroki M; Ariumi Y; Wakita T; Ikeda M
Virus Res; 2009 Dec; 146(1-2):41-50. PubMed ID: 19720094
[TBL] [Abstract][Full Text] [Related]
30. Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers.
Steenbergen RH; Joyce MA; Thomas BS; Jones D; Law J; Russell R; Houghton M; Tyrrell DL
Hepatology; 2013 Dec; 58(6):1907-17. PubMed ID: 23775894
[TBL] [Abstract][Full Text] [Related]
31. Acquisition of susceptibility to hepatitis C virus replication in HepG2 cells by fusion with primary human hepatocytes: establishment of a quantitative assay for hepatitis C virus infectivity in a cell culture system.
Ito T; Yasui K; Mukaigawa J; Katsume A; Kohara M; Mitamura K
Hepatology; 2001 Sep; 34(3):566-72. PubMed ID: 11526543
[TBL] [Abstract][Full Text] [Related]
32. Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.
Gottwein JM; Bukh J
Adv Virus Res; 2008; 71():51-133. PubMed ID: 18585527
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro.
Iacovacci S; Manzin A; Barca S; Sargiacomo M; Serafino A; Valli MB; Macioce G; Hassan HJ; Ponzetto A; Clementi M; Peschle C; Carloni G
Hepatology; 1997 Nov; 26(5):1328-37. PubMed ID: 9362380
[TBL] [Abstract][Full Text] [Related]
34. Genotype 1a HCV (H77S) infection system.
Yi M; Lemon SM
Methods Mol Biol; 2009; 510():337-46. PubMed ID: 19009273
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
36. Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity.
Bankwitz D; Doepke M; Hueging K; Weller R; Bruening J; Behrendt P; Lee JY; Vondran FWR; Manns MP; Bartenschlager R; Pietschmann T
J Hepatol; 2017 Sep; 67(3):480-489. PubMed ID: 28438690
[TBL] [Abstract][Full Text] [Related]
37. Establishment of persistent hepatitis C virus infection and replication in vitro.
Seipp S; Mueller HM; Pfaff E; Stremmel W; Theilmann L; Goeser T
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2467-76. PubMed ID: 9349466
[TBL] [Abstract][Full Text] [Related]
38. [HCV replication in Huh-7.5 cell line].
Komorowski M; Kołakowska A; Godzik P; Madaliński K
Med Dosw Mikrobiol; 2012; 64(3):239-44. PubMed ID: 23285778
[TBL] [Abstract][Full Text] [Related]
39. Thermostable hepatitis C virus JFH1-derived variant isolated by adaptation to Huh7.5.1 cells.
Shirasago Y; Fukazawa H; Aizaki H; Suzuki T; Suzuki T; Sugiyama K; Wakita T; Hanada K; Abe R; Fukasawa M
J Gen Virol; 2018 Oct; 99(10):1407-1417. PubMed ID: 30045785
[TBL] [Abstract][Full Text] [Related]
40. Transfection of a differentiated human hepatoma cell line (Huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV.
Yoo BJ; Selby MJ; Choe J; Suh BS; Choi SH; Joh JS; Nuovo GJ; Lee HS; Houghton M; Han JH
J Virol; 1995 Jan; 69(1):32-8. PubMed ID: 7983724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
